FLUMETOL 2mg / 1mg / ml ophthalmic drops suspension medication leaflet

S01BB03 fluorometholone + tetrahydrozoline • Sensory organs | Antiinflammatory agents | Corticosteroids and mydriatics in combination

Fluorometholone and tetrahydrozoline are used together in ophthalmic medications for the treatment of eye inflammation associated with congestion and irritation. This combination is indicated for conditions such as allergic conjunctivitis, eye irritation caused by external factors (dust, smoke, pollen), or other minor eye inflammations.

- Fluorometholone is a corticosteroid with anti-inflammatory properties that reduces inflammation, redness, and swelling in the eyes. It works by inhibiting the body's inflammatory response, alleviating symptoms associated with allergies or eye irritation.
- Tetrahydrozoline is a decongestant that acts by constricting blood vessels in the eyes, quickly reducing redness and ocular congestion. This effect helps relieve discomfort and improve the appearance of the eyes.

While effective, this combination may cause some side effects. The most common include a burning or stinging sensation upon application, dry eyes, or temporary blurred vision. In rare cases, prolonged use of corticosteroids can lead to increased intraocular pressure, cataracts, or secondary eye infections. It is important that the treatment is used short-term and under medical supervision.

This combination should be used as directed by a doctor, and patients should adhere to the prescribed dosage and duration of treatment. It is contraindicated in patients with active eye infections (bacterial, viral, or fungal) or hypersensitivity to any of the components. If symptoms persist or worsen, an immediate ophthalmological consultation is necessary.

General data about FLUMETOL 2mg / 1mg / ml

Substance: fluorometholone + tetrahydrozoline

Date of last drug list: 01-01-2019

Commercial code: W59769001

Concentration: 2mg / 1mg / ml

Pharmaceutical form: ophthalmic drops suspension

Packing volume: 5ml

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FARMILA-THEA FARMACEUTICI S.P.A. - ITALIA

Holder: THEA FARMA S.P.A. - ITALIA

Number: 10046/2017/01

Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-30 days